Single User License
INR 130358
Site License
INR 260715
Corporate User License
INR 391073

Service Tax Additional

select a format

Single User License
USD 1950
Site License
USD 3900
Corporate User License
USD 5850


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"

Pharmaceutical Industry Business Confidence Report H1 2016

Pharmaceutical Industry Business Confidence Report H1 2016

  Request for Sample Report

Executive Summary

The existing economic environment is stable for the pharmaceutical industry, and customer confidence levels will remain constant in H1 2016 (January 2016-June 2016). Companies are slightly optimistic about economic conditions in North America and Asia-Pacific due to positive momentum in the US manufacturing and production sectors, firm domestic demand, strong government expenditure in India, and robust private consumption and export growth in South Korea and Vietnam. Over the next six months the industry will increase its expenditure towards new product development and IT infrastructure. Moreover, companies operating in Asia-Pacific forecast their budget allocation for pharmaceutical equipment to increase significantly in 2016, compared to 2015.

Key Findings

In total, 43% of pharmaceutical industry business executives expect the global economy to be stable in H1 2016 (January 2016-June 2016). Furthermore, 33% of survey respondents anticipate a favorable or very favorable economic environment

Overall, 83% of respondents who operate in Europe are optimistic over company growth prospects, while no executives anticipate a negative impact on the industry in the region

Business executives operating in the Rest of the World region anticipate the highest increase in staff headcount growth over the next six months

In H1 2016, the majority of business executives from North America are concerned about the performance of North American economies, the performance of the Eurozone, and cyber crime

Survey results reveal that 41% of pharmaceutical industry respondents who operate in Asia-Pacific expect an increase of 1-5% in the budget for pharmaceutical equipment during 2016


Kables pharmaceutical Industry Business Confidence Survey H1 2016 examines executives opinion on the business environment over January-June 2016. It also highlights existing economic conditions, supplier price variations, sales performance, industry and company growth outlook, spending patterns, and key priorities. Additionally, the report includes trends in the pharmaceutical equipment market, analysis of the procurement budget allocations, and leading suppliers of pharmaceutical equipment.

What else does this report offer?

Current state of the global economy: examines prevailing economic conditions globally and across various regions

Company and industry growth outlook: provides industry executives expectations towards the growth prospects of their company and the industry over the next six months

Change in customer confidence: analyzes pharmaceutical industry executives opinion about the change in customer confidence during H1 2016

Supplier prices projection: determines expected change in supplier prices across various categories and their impact on business confidence

Change in staff headcount and sales performance: tracks expected change in staff headcount and sales for H1 2016 among industry executives globally

Significant investment activities: highlights various areas in which industry executives intend to invest over the next six months

Business concerns: provides information about potential business concerns indicated by survey respondents for H1 2016

Key priorities: identifies the top priorities of industry executives operating in various regions

Purchase preferences: analyzing the purchasing behavior towards pharmaceutical equipment and investment allocations in the pharmaceutical equipment categories

Budget allocation: examining total procurement budget split between capital expenditure and operating expenditure, and tracking the changes in the budget for 2015 and expectations for 2016

Reasons To Buy

Helps organizations to make effective business strategy decisions by knowing the prevailing business conditions and sentiment within the pharmaceutical industry

Organizations will be supported in business expansion decisions by providing information about projected change in sales performance and supplier prices

Helps to improve operational efficiency of the organization by knowing about key priorities and the main concerns of pharmaceutical industry executives

Helps to alter investment allocation by understanding key focus areas highlighted by survey respondents during H1 2016

Enables organizations to make key decisions on purchase preferences and investments in pharmaceutical equipment



Methodology and sample size

Respondent profile

Economic State, growth prospects and customer confidence

Existing economic environment

Industry and company growth outlook

Expected change in customer confidence

Supplier prices, staff headcount and sales performance

Supplier prices expectations

Anticipated change in staff head count and sales projections

Anticipated change in spend on key activities

Business concerns and organizational priorities

Level of concerns and expected impact

Significance of potential business priorities

Procurement budget and expenditure outlook

Purchase preferences for pharmaceutical equipment

Frequency of investments towards various equipment categories

Procurement of number of pieces of equipment

Average expenditure per purchase

Allocation of investment for equipment purchases

Distribution of procurement budget between capital and operating expenditure

Change in procurement budget expenditure

Variation in pharmaceutical equipment budget from 2015 to 2016

Leading suppliers across pharmaceutical equipment types


Figure 1: Current economic condition - Overall

Figure 2: Current economic condition - Region

Figure 3: Current economic condition - Those who operate and do not operate in a region

Figure 4: Industry and company growth prospects - Overall

Figure 5: Industry and company growth prospects - Overall - In detail

Figure 6: Industry and company growth prospects - Region

Figure 7: Anticipated variation in customer confidence - Overall

Figure 8: Anticipated variation in customer confidence - Region

Figure 9: Projected change in supplier prices - Raw Materials - Overall and regional

Figure 10: Projected change in supplier prices - Semi-finished products - Overall and regional

Figure 11: Projected change in supplier prices - Packaging - Overall and regional

Figure 12: Projected change in supplier prices - Ingredients - Overall and regional

Figure 13: Staff headcount and sales outlook - Regional

Figure 14: Expenditure projection on key activities - Overall

Figure 15: Top five business concerns - Region

Figure 16: Business concerns - Overall and regional

Figure 17: Business concerns - Overall and regional

Figure 18: Top five organizational priorities - Region

Figure 19: Organizational priorities - Overall and region

Figure 20: Purchase preferences - Region

Figure 21: Frequency of investments - Overall

Figure 22: Procurement of number of pieces of equipment - Overall

Figure 23: Average expenditure per purchase - Overall

Figure 24: Investment allocation for equipment purchases - Region

Figure 25: Distribution of procurement budget - Region

Figure 26: Change in procurement budget expenditure - Region

Figure 27: Change in pharmaceutical equipment budget - Region

Figure 28: Leading suppliers across pharmaceutical equipment types - Overall

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Johnson & Johnson (Pty) Ltd

Albany Molecular Research (AMRI)

New York Center for Nanomedicine Research (NYCNMR)

GlaxoSmithKline (GSK)




Business Confidence, Economic Outlook, Pharmaceutical, Raw Materials, Semi-finished Products, Packaging, Ingredients, Global, Supplier, Equipment, Staff Headcount, Sales Performance, Spending, Customer Confidence, Threats And Priorities, Growth Prospects, Procurement, Budget, Capital Expenditure, Operating Expenditure

Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]